We are live on ! Find out more
CNAM

Campbell Newman Asset Management Portfolio holdings

AUM $1.35B
1-Year Est. Return 38.87%
This Fund
S&P 500
This Quarter Est. Return
+13.35%
1 Year Est. Return
+38.87%
3 Year Est. Return
+107.92%
5 Year Est. Return
+146.05%
10 Year Est. Return
+543.08%
AUM
$648M
AUM Growth
+$72.6M
Cap. Flow
-$138K
Cap. Flow %
-0.02%
Top 10 Hldgs %
36.96%
Holding
125
New
1
Increased
65
Reduced
34
Closed
1

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$7.88M
2
BA icon
Boeing
BA
+$2.34M
3
MRK icon
Merck
MRK
+$2.21M
4
EMN icon
Eastman Chemical
EMN
+$704K
5
MPC icon
Marathon Petroleum
MPC
+$669K

Sector Composition

Rank Sector Weight
1 Technology 27.28%
2 Healthcare 19.63%
3 Financials 11.61%
4 Industrials 10.79%
5 Consumer Discretionary 10.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTU
101
DELISTED
Virtusa Corporation
VRTU
$539K 0.08%
10,078
+251
+3% +$12.4K
MPWR icon
102
Monolithic Power Systems
MPWR
$68.9B
$530K 0.08%
3,912
+92
+2% +$12.1K
IART icon
103
Integra LifeSciences
IART
$1.34B
$517K 0.08%
9,278
+218
+2% +$11.1K
CMD
104
DELISTED
Cantel Medical Corporation
CMD
$515K 0.08%
7,706
+183
+2% +$13.9K
LGIH icon
105
LGI Homes
LGIH
$1.4B
$483K 0.07%
8,017
+197
+3% +$11.4K
VRNT
106
DELISTED
Verint Systems
VRNT
$483K 0.07%
15,843
+369
+2% +$9.38K
MMM icon
107
3M
MMM
$94.3B
$478K 0.07%
2,751
EGRX
108
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$476K 0.07%
9,437
+234
+3% +$10.4K
CELG
109
DELISTED
Celgene Corp
CELG
$468K 0.07%
4,958
+38
+0.8% +$3.32K
CARO
110
DELISTED
Carolina Financial Corp.
CARO
$444K 0.07%
12,836
+395
+3% +$13.7K
CONE
111
DELISTED
CyrusOne Inc Common Stock
CONE
$426K 0.07%
8,117
+188
+2% +$9.84K
DY icon
112
Dycom Industries
DY
$12.3B
$413K 0.06%
8,994
+214
+2% +$11.7K
JCI icon
113
Johnson Controls International
JCI
$92.2B
$402K 0.06%
10,890
MC icon
114
Moelis & Co
MC
$4.94B
$402K 0.06%
9,656
+297
+3% +$12.7K
FNKO icon
115
Funko
FNKO
$328M
$397K 0.06%
18,298
+496
+3% +$9.11K
NUVA
116
DELISTED
NuVasive, Inc.
NUVA
$387K 0.06%
6,807
+166
+2% +$8.82K
CORT icon
117
Corcept Therapeutics
CORT
$12B
$371K 0.06%
31,637
+815
+3% +$10.1K
FOE
118
DELISTED
Ferro Corporation
FOE
$348K 0.05%
18,408
+482
+3% +$8.5K
QRVO icon
119
Qorvo
QRVO
$8.74B
$286K 0.04%
3,990
+139
+4% +$9.2K
PARA
120
DELISTED
Paramount Global Class B
PARA
$246K 0.04%
5,186
+198
+4% +$9.65K
ORLY icon
121
O'Reilly Automotive
ORLY
$76.3B
$233K 0.04%
9,000
PM icon
122
Philip Morris
PM
$295B
$233K 0.04%
2,635
-2,500
-49% -$201K
SPY icon
123
State Street SPDR S&P 500 ETF Trust
SPY
$810B
$215K 0.03%
760
-3,248
-81% -$882K
PBCT
124
DELISTED
People's United Financial Inc
PBCT
$164K 0.03%
10,000
LGND icon
125
Ligand Pharmaceuticals
LGND
$6.36B
-6,547
Closed -$554K

Similar funds

Campbell Newman Asset Management's Q1 2019 Portfolio in Review

As of Q1 2019, Campbell Newman Asset Management held 125 positions worth $648M, up 13% from $575M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Trading was light in Q1 2019: portfolio turnover was 1.6%. Campbell Newman Asset Management opened 1 new position and exited 1, leaving the 125-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

  • Campbell Newman Asset Management's largest Q1 2019 buy was Medifast: 4,343 shares worth $554K.
  • Campbell Newman Asset Management added most to Eli Lilly in Q1 2019, an estimated $7.88M increase.
  • Campbell Newman Asset Management's biggest Q1 2019 reduction was SunTrust Banks, Inc., cutting an estimated $5.86M.
  • Campbell Newman Asset Management fully exited Ligand Pharmaceuticals in Q1 2019, selling an estimated $554K.
  • Campbell Newman Asset Management's ten largest holdings make up 37% of its $648M portfolio in Q1 2019.
  • Campbell Newman Asset Management opened 1 new position and closed 1 in Q1 2019.
  • Campbell Newman Asset Management's portfolio value rose 13% quarter-over-quarter to $648M.

Based on Campbell Newman Asset Management's 13F filing for Q1 2019, filed 9 Apr 2019.